COVID-19 and Severe Asthma: Reflections and Future Solutions [Letter]

por Domínguez-Ortega, Javier, Sánchez-García, Silvia, Melero Moreno, Carlos
Publicado 2022

Mepolizumab and COPD in Real Life

por Revuelta-Salgado, Fernando, Díaz-Campos, Rocío Magdalena, Hernando-Sanz, Ascensión, Melero-Moreno, Carlos
Publicado 2021

Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach

por López-Viña, Antolín, Díaz Campos, Rocío M., Trisan Alonso, Andrea, Melero Moreno, Carlos
Publicado 2022

Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach

por López-Viña, Antolín, Diaz Campos, Rocio M., Trisan Alonso, Andrea, Melero Moreno, Carlos
Publicado 2023

Molecular T2 asthma phenotypes are stable but heterogeneous: the usefulness of periostin for endotyping

por Bobolea, Irina, Guillén-Vera, Daniela, De las Cuevas-Moreno, Natividad, García-Granero, Diego Blanco, Loli-Ausejo, David, Melero-Moreno, Carlos
Publicado 2023

Does Airway T2 Inflammation Increase the Severity of Bronchial Hyperresponsiveness?

por Jiménez-Gómez, Miguel, Díaz Campos, Rocío Magdalena, Catalinas Muñoz, Eduardo, Díaz Miravalls, Julia, Peña del Cura, María Begoña, Melero Moreno, Carlos, García García, Rocío
Publicado 2023